Healthy Volunteer Recruitment and Characterization for NINDS Studies
Background:
The National Institute of Neurological Disorders and Stroke (NINDS) often enrolls healthy volunteers in certain studies. These studies allow researchers to look for causes of diseases and disorders by comparing affected people to healthy ones. Prescreening lets volunteers participate in multiple studies without having to repeat the screening tests each time. Having a registry of prescreened volunteers also makes it easier for researchers to reach people willing to participate in their studies.
Objective:
To create a registry of healthy volunteers who have been prescreened for NINDS research studies.
Eligibility:
Healthy people aged 18 years and older.
Design:
Participants will have 1 clinic visit for prescreening. This visit will take about 5 hours. The visit may be spread across 1 to 3 days.
Participants will have the following procedures:
A physical exam, including height, weight, and vital signs.
A review of their medical history and medications. They will also provide personal data such as age, sex, and years of education.
An exam of their nervous system. This will include tests of their strength and reflexes, following an object with their eyes, and other tasks.
Cognitive tests. These tests will check their memory, attention, and thinking.
A magnetic resonance imaging (MRI) scan. They will lie on a table that slides into a cylinder; Magnetic fields will create images of their brain.
Handedness. They will complete a questionnaire about what hand they use for most tasks.
Participants may remain on the healthy volunteers list for 2 years. If they wish to participate longer, they will need to return to repeat all of the screening tests.
Aperçu de l'étude
Statut
Les conditions
Description détaillée
Study Description:
This protocol will create a registry of healthy volunteers for intramural NINDS. It will provide a vehicle for recruiting, examination, and preliminary testing of healthy research volunteers for NINDS studies. We plan to retain data for use in future research by creating a repository.
Objectives:
To provide a centralized and standardized service for recruiting, screening, and characterizing healthy volunteers by creating a repository for secondary research
Type d'étude
Inscription (Estimé)
Contacts et emplacements
Coordonnées de l'étude
- Nom: Eric M Wassermann, M.D.
- Numéro de téléphone: (301) 496-0151
- E-mail: wassermanne@nih.gov
Lieux d'étude
-
-
Maryland
-
Bethesda, Maryland, États-Unis, 20892
- National Institutes of Health Clinical Center
-
Contact:
- NIH Clinical Center Office of Patient Recruitment (OPR)
- Numéro de téléphone: TTY dial 711 (800) 411-1222
- E-mail: ccopr@nih.gov
-
Contact:
- Eric Wassermann, M.D.
- Numéro de téléphone: 301-496-0151
- E-mail: wassermanne@nih.gov
-
-
Critères de participation
Critère d'éligibilité
Âges éligibles pour étudier
- Adulte
- Adulte plus âgé
Accepte les volontaires sains
Méthode d'échantillonnage
Population étudiée
La description
- INCLUSION CRITERIA
To be eligible to participate in this study, an individual must meet all the following criteria:
- Stated interest in, and availability for, participating in NINDS studies and willingness to comply with the procedures of this protocol.
- At least 18 years of age.
- Ability to understand and willingness to sign a written informed consent document.
- Fluent in English, or another language that allows the use of a validated MoCA or MoCA Duo to be completed (see the following list of languages Paper (mocacognition.com) or Digital tools (mocacognition.com))
EXCLUSION CRITERIA
An individual who meets any of the following criteria will be excluded from participation in this study:
- Major neurological or neurobehavioral disorder, such as seizure disorder, multiple sclerosis, major depression, or schizophrenia.
- Substance use disorder or illicit substance use.
- Deafness or blindness to a degree which would make participation in studies impossible, e.g., inability to communicate with investigators or read instructions.
- Identified major health concerns (e.g., uncontrolled diabetes mellitus, congestive heart failure, liver cirrhosis, malignancy requiring ongoing cytotoxic chemotherapy, immunotherapy, or radiation) as evidenced by screening medical history.
- Presence of implanted electronic devices, e.g., pacemakers, or other implanted object(s) making MRI unsafe or whose safety cannot be ascertained.
- Inability to tolerate MRI scanning for any reason.
- Pregnancy.
Plan d'étude
Comment l'étude est-elle conçue ?
Détails de conception
Cohortes et interventions
Groupe / Cohorte |
|---|
|
Volontaires en bonne santé
|
Que mesure l'étude ?
Principaux critères de jugement
Mesure des résultats |
Délai |
|---|---|
|
To screen and create a temporary list of volunteers in good health for participation in NINDS studies (Volunteer List) in order to reduce costs, inconvenience to volunteers, and duplication of effort.
Délai: From enrollment/consent until withdrawal from the registry or study closure.
|
From enrollment/consent until withdrawal from the registry or study closure.
|
Collaborateurs et enquêteurs
Les enquêteurs
- Chercheur principal: Eric M Wassermann, M.D., National Institute of Neurological Disorders and Stroke (NINDS)
Publications et liens utiles
Liens utiles
Dates d'enregistrement des études
Dates principales de l'étude
Début de l'étude (Estimé)
Achèvement primaire (Estimé)
Achèvement de l'étude (Estimé)
Dates d'inscription aux études
Première soumission
Première soumission répondant aux critères de contrôle qualité
Première publication (Réel)
Mises à jour des dossiers d'étude
Dernière mise à jour publiée (Réel)
Dernière mise à jour soumise répondant aux critères de contrôle qualité
Dernière vérification
Plus d'information
Termes liés à cette étude
Autres numéros d'identification d'étude
- 10002262
- 002262-N
Plan pour les données individuelles des participants (IPD)
Prévoyez-vous de partager les données individuelles des participants (DPI) ?
Informations sur les médicaments et les dispositifs, documents d'étude
Étudie un produit pharmaceutique réglementé par la FDA américaine
Étudie un produit d'appareil réglementé par la FDA américaine
Ces informations ont été extraites directement du site Web clinicaltrials.gov sans aucune modification. Si vous avez des demandes de modification, de suppression ou de mise à jour des détails de votre étude, veuillez contacter register@clinicaltrials.gov. Dès qu'un changement est mis en œuvre sur clinicaltrials.gov, il sera également mis à jour automatiquement sur notre site Web .
Essais cliniques sur En bonne santé
-
AstraZenecaParexelComplété